RankAlpha logo
Back to Rankings

CHRS

Coherus OncologyF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
CHRS vs peer average
28/100
CHRS vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · D 4 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

NAUT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $216.03M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerNAUTNautilus Biotechnology
CHRS
Coherus Oncology
NAUT
Nautilus Biotechnology
Grade
F
D
Momentum
18
49
Value
41
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs NAUT

CHRS / NAUT
Grade Position
Below peers
CHRS vs. peer average (F vs. D)
28/100
Momentum
18
NAUT
Value
41
CHRS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CHRS
1
NAUT
Nautilus Biotechnology Inc Common
D
40/100
-1
2
OTLK
Outlook Therapeutics Inc Common
F
20/100
Even
3
WHWK
Whitehawk Therapeutics Inc Common
F
20/100
Even
4
CGEN
Compugen Ltd Common
B
80/100
-3
5
TARA
Protara Therapeutics Inc Common
D
40/100
-1
NAUT is the first peer returned for this comparison set.